Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.4K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

548
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
548
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

427
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
427
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

637
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
637
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

336
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
336
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

391
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
391

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.

The American journal of cardiology·2013
Same author

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.

Circulation·2013
Same author

Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.

Clinical cardiology·2013
Same author

Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes.

Circulation·2013
Same author

Lipoprotein(a) for risk assessment in patients with established coronary artery disease.

Journal of the American College of Cardiology·2013
Same author

Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.

JAMA·2013

Video Experimental Relacionado

Updated: Mar 16, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

29.0K

Infarto agudo del miocardio

Grant W Reed1, Jeffrey E Rossi1, Christopher P Cannon2

  • 1Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.

Lancet (London, England)
|August 10, 2016
PubMed
Resumen

El manejo del infarto agudo de miocardio (AMI) se simplifica mediante el tratamiento del MI de elevación ST y no elevación ST de manera similar. Los avances en la reperfusión, la terapia antiplaquetaria y la prevención secundaria mejoran los resultados para esta principal causa de muerte.

Más Videos Relacionados

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
08:38

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

29.8K
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.8K

Videos de Experimentos Relacionados

Last Updated: Mar 16, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

29.0K
Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
08:38

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

29.8K
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.8K

Área de la Ciencia:

  • Cardiología
  • Médico interno
  • Salud pública

Sus antecedentes:

  • El infarto agudo del miocardio (AMI) es una de las principales causas de morbilidad y mortalidad en todo el mundo.
  • A pesar de las mejoras, la IAM sigue siendo un desafío significativo para la salud en todo el mundo.
  • La clasificación tradicional en MI de elevación ST y MI de no elevación ST puede simplificarse para la gestión.

Objetivo del estudio:

  • Revisar la fisiopatología, la epidemiología y el manejo moderno de la IAM.
  • Destacar los avances recientes en las estrategias de reperfusión y los tratamientos farmacológicos para la IAM.
  • Hacer hincapié en un enfoque unificado para la gestión de AMI.

Principales métodos:

  • Revisión de la literatura actual sobre la fisiopatología y la epidemiología de las IAM.
  • Análisis de las tendencias en la estratificación del riesgo y las estrategias invasivas.
  • Evaluación de los avances en los agentes antiplaquetarios, anticoagulantes y tratamiento con estatinas.
  • Discusión de las técnicas de reperfusión contemporáneas, incluida la intervención coronaria percutánea y la fibrinólisis.

Principales resultados:

  • Progreso significativo en el pronóstico de la IAM en la última década.
  • Aumento de la utilización de estrategias invasivas y revascularización rápida.
  • Mayor eficacia de las terapias antiplaquetarias y anticoagulantes.
  • Mayor adopción de medidas de prevención secundaria como las estatinas.

Conclusiones:

  • Un enfoque simplificado y unificado para la gestión de las AMI es factible y beneficioso.
  • Los avances continuos en la reperfusión y la farmacoterapia son cruciales para mejorar los resultados de la IAM.
  • Las estrategias eficaces de prevención secundaria siguen siendo esenciales para reducir la morbilidad y la mortalidad a largo plazo.